Return On Equity of Inhibikase Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Inhibikase Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Inhibikase Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -57%, a 84% increase year-over-year.
  • Inhibikase Therapeutics, Inc. annual Return On Equity for 2024 was -104%, a 3.7% increase from 2023.
  • Inhibikase Therapeutics, Inc. annual Return On Equity for 2023 was -108%, a 63% decline from 2022.
  • Inhibikase Therapeutics, Inc. annual Return On Equity for 2022 was -66%, a 52% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Inhibikase Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -57% +293% +84% 01 Jul 2025 30 Sep 2025
Q2 2025 -64% +130% +67% 01 Apr 2025 30 Jun 2025
Q1 2025 -79% +68% +46% 01 Jan 2025 31 Mar 2025
Q4 2024 -104% +4% +3.7% 01 Oct 2024 31 Dec 2024
Q3 2024 -351% -256% -270% 01 Jul 2024 30 Sep 2024
Q2 2024 -194% -110% -132% 01 Apr 2024 30 Jun 2024
Q1 2024 -147% -76% -107% 01 Jan 2024 31 Mar 2024
Q4 2023 -108% -42% -63% 01 Oct 2023 31 Dec 2023
Q3 2023 -95% -35% -60% 01 Jul 2023 30 Sep 2023
Q2 2023 -84% -32% -62% 01 Apr 2023 30 Jun 2023
Q1 2023 -71% -30% -72% 01 Jan 2023 31 Mar 2023
Q4 2022 -66% -23% -52% 01 Oct 2022 31 Dec 2022
Q3 2022 -59% -19% -46% 01 Jul 2022 30 Sep 2022
Q2 2022 -52% -3.9% -8.2% 01 Apr 2022 30 Jun 2022
Q1 2022 -41% +210% +84% 01 Jan 2022 31 Mar 2022
Q4 2021 -43% -277% -119% 01 Oct 2021 31 Dec 2021
Q3 2021 -41% 01 Jul 2021 30 Sep 2021
Q2 2021 -48% 01 Apr 2021 30 Jun 2021
Q1 2021 -251% 01 Jan 2021 31 Mar 2021
Q4 2020 234% 01 Oct 2020 31 Dec 2020

Inhibikase Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -104% +4% +3.7% 01 Jan 2024 31 Dec 2024
2023 -108% -42% -63% 01 Jan 2023 31 Dec 2023
2022 -66% -23% -52% 01 Jan 2022 31 Dec 2022
2021 -43% -277% -119% 01 Jan 2021 31 Dec 2021
2020 234% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.